Cubist Pharmaceuticals Wins Awards (NASDAQ:CBST)

It was a Wednesday afternoon when Cubist Pharmaceuticals have publicly announced that they have been named to be in the top spot in the MassEcon Sixth Annual Team Massachusetts Economic Impact Awards in the Greater Boston Region. The Massachusetts Alliance for Economic Development also known as MassEcon is a private, non-profit partnership of business, industry leaders and government who are working hard for the economic growth of Massachusetts. With two other pharmaceutical companies bagging the silver and bronze level, it was the life science companies that sweep the awards in the Greater Boston Region.

Cubist Pharmaceuticals Inc. is a biopharmaceutical company that is into the research and development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

The winning companies were judged on their investment in facilities, job growth and community involvement. Cubist Pharmaceuticals that is headquartered in Lexington, MA had added 35,000 square feet of lab space at its Hayden Avenue facility previous year. The company has further plans to add another 110,000 square feet of lab space in the next couple of years in the Lexington area. Currently, Cubist Pharmaceuticals employs 579 people, of which 350 work in the Lexington facility and the rest in the other facilities available.